Rocket Doctor AI says U.S. patient visits surged in first two months of Q3

Rocket Doctor AI reported stronger U.S. operating metrics for July and August 2026 ahead of a Sept. 14 global town hall, including 3,625 completed patient visits and 1,555 clinical hours. The update points to faster volume growth, but revenue recognition still lags because some U.S. payments are recorded on a cash basis.

Why it matters: - Rocket Doctor AI is showing momentum in its U.S. business before it updates investors at a global town hall. - Higher visit volume can support future revenue growth, but the company still faces a timing gap between care delivered and cash recognized. - The update also highlights a key scaling issue in U.S. telehealth: converting out-of-network activity into reimbursable in-network care.

What happened: - Rocket Doctor AI issued a pre-town hall operational update on Sept. 14, 2026, covering its U.S. business for July and August 2026. - The company reported 3,625 completed U.S. patient visits in the two-month period ending Aug. 31, 2026. - That visit count equaled 93% of the 3,911 completed visits the company recorded in all of Q2 2026. - U.S. clinical hours rose to 1,555 hours for July and August, or 78% of the 1,987.5 hours logged in Q2 2026. - The company said the update was meant to put the information in the public domain before its global town hall scheduled for Sept. 14, 2026. - The town hall was set for 1 p.m. Pacific time / 4 p.m. Eastern time on Zoom: Zoom webinar.

The details: - Rocket Doctor AI recognizes some U.S. revenue on a cash basis. - That accounting approach creates a lag between rising patient visits and revenue recognition. - The company distinguishes between in-network and out-of-network patients when determining reimbursement eligibility. - For in-network visits, both the patient and the treating physician must be enrolled with the applicable insurer, Medicare or Medicaid for a claim to be eligible for payment. - For out-of-network visits, Rocket Doctor AI has chosen to allow platform access to help drive adoption and expand its user base during the early stage of U.S. market development. - The company said reimbursement for out-of-network visits is generally not expected. - Rocket Doctor AI will still submit claims for out-of-network visits where possible, because some claims could be approved at the payor’s discretion. - Any cash recovered from out-of-network claims is recognized as revenue only when received. - Management said it will keep working to convert out-of-network patients and physicians to in-network status over time. - The company expects that shift to improve reimbursement rates and give it better revenue visibility. - Rocket Doctor AI said its Global Library of Medicine, or GLM, is a clinically validated decision support system developed with input from hundreds of physicians worldwide. - The company said its technology has helped empower more than 350 doctors to provide care for more than 750,000 patient visits. - Rocket Doctor AI said its software lets doctors launch and manage virtual or hybrid in-person practices independently. - The company said it aims to support underserved, rural and remote communities in Canada, and patients on Medicaid and Medicare in the United States. - Rocket Doctor AI said more information is available at the company’s website and via email at info@rocketdoctor.ai. - The release also identified Rocket Doctor AI as a B2i Digital Featured Company with a profile at the company’s profile. - The release linked to the company’s disclosure filings on SEDAR+.

Between the lines: - The operating update suggests demand is rising faster than revenue recognition, which can make near-term financial results look weaker than underlying utilization. - The out-of-network strategy appears designed to prioritize platform growth now, with reimbursement optimization later. - The heavy emphasis on in-network conversion signals that payer relationships may be a key driver of margin and visibility going forward.

What's next: - Rocket Doctor AI planned to discuss the update in more detail during its Sept. 14 global town hall. - The company said management will continue evaluating network coverage and payor relationships to increase in-network participation over time. - Future revenue visibility will likely depend on whether patient volume translates into more reimbursable visits and faster cash collection.

The bottom line: - Rocket Doctor AI is scaling U.S. care activity, but the path to cleaner revenue growth still depends on reimbursement, network expansion and cash timing.